NYSE · Materials
Chemours Co (CC)
As-reported financials and recent SEC filings for Chemours Co, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.81B
Net income
$-386.0M
Net margin
-6.6%
Diluted EPS
$-2.57
ROE
-153.8%
P/E (TTM)
—
Market cap
$3.31B
Debt / equity
16.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.81B | $5.78B | $6.08B | $6.83B | $6.34B |
| Gross profit | $902.0M | $1.14B | $1.30B | $1.62B | $1.38B |
| Operating income | — | — | — | — | — |
| Net income | $-386.0M | $69.0M | $-253.0M | $578.0M | $608.0M |
| Diluted EPS | $-2.57 | $0.46 | $-1.70 | $3.65 | $3.60 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-27
View on EDGAR →42026-05-08
View on EDGAR →42026-05-08
View on EDGAR →42026-05-08
View on EDGAR →42026-05-08
View on EDGAR →42026-05-08
View on EDGAR →42026-05-08
View on EDGAR →42026-05-08
View on EDGAR →Go deeper on CC
Search Chemours Co’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.